110 related articles for article (PubMed ID: 2994615)
1. Immunofluorescence and electron microscopic investigations of epithelial hybrid cells derived from nasopharyngeal carcinoma (NPC-KT).
Takimoto T; Morishita K; Ishiguro H; Umeda R
Auris Nasus Larynx; 1985; 12(1):37-45. PubMed ID: 2994615
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
Takimoto T; Umeda R; Ogura H; Hatano M
Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) receptors on epithelial hybrid cells derived from nasopharyngeal carcinoma.
Takimoto T; Tanaka S; Ishikawa S; Umeda R
ORL J Otorhinolaryngol Relat Spec; 1990; 52(2):69-74. PubMed ID: 2158034
[TBL] [Abstract][Full Text] [Related]
5. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
Glaser R; Zhang HY; Yao KT; Zhu HC; Wang FX; Li GY; Wen DS; Li YP
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
Takimoto T; Sato H; Ogura H; Miyazaki T
Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
Takimoto T; Kamide M; Umeda R
Arch Otorhinolaryngol; 1984; 239(1):87-92. PubMed ID: 6318711
[TBL] [Abstract][Full Text] [Related]
8. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
Takimoto T; Sato H; Ogura H; Ogura T; Ishikawa S; Iwawaki J
ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):169-74. PubMed ID: 2819802
[TBL] [Abstract][Full Text] [Related]
9. Effects of human interferon on cell proliferation and antigens induced by Epstein-Barr virus in epithelial hybrid cells derived from nasopharyngeal carcinoma.
Takimoto T; Ishikawa S; Umeda R; Ogura H; Hatano M
Otolaryngol Head Neck Surg; 1985 Aug; 93(4):500-4. PubMed ID: 2995902
[TBL] [Abstract][Full Text] [Related]
10. Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma.
Trumper PA; Epstein MA; Giovanella BC; Finerty S
Int J Cancer; 1977 Nov; 20(5):655-62. PubMed ID: 200568
[TBL] [Abstract][Full Text] [Related]
11. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
Takimoto T; Sato H; Ogura H; Miyazaki T
Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
[TBL] [Abstract][Full Text] [Related]
12. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells.
Takimoto T; Furukawa M; Hatano M; Umeda R
Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641
[TBL] [Abstract][Full Text] [Related]
14. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
Takimoto T; Umeda R
Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
[TBL] [Abstract][Full Text] [Related]
16. Activation in vitro by BUdR of a productive EB virus infection in the epithelial cells of nasopharyngeal carcinoma.
Trumper PA; Epstein MA; Giovanella BC
Int J Cancer; 1976 May; 17(5):578-87. PubMed ID: 178612
[TBL] [Abstract][Full Text] [Related]
17. Epithelial characteristics of tumor cells in nasophasyngeal carcinoma.
de-Thé G; Vuillaume M; Giovanella BC; Klein G
J Natl Cancer Inst; 1976 Nov; 57(5):1101-5. PubMed ID: 187791
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies in the sera of patients with nasopharyngeal carcinoma.
Takimoto T; Ishikawa S; Masuda K; Tanaka S; Yoshizaki T; Umeda R
Am J Otolaryngol; 1989; 10(6):399-403. PubMed ID: 2556945
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
